Clinical Trials Browser

NIH × Melanoma × Temozolomide × Clear all

NCT01196416 2019-11-18

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma

Phase 1/2 Completed

14 enrolled 16 charts

Melanoma

NCT00003747 2013-09-20

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00016055 2013-09-20

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00072163 2013-01-17

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Phase 2 Completed

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma